Literature DB >> 7630247

3849+10 kb C-->T mutation and disease severity in cystic fibrosis.

R C Stern1, C F Doershuk, M L Drumm.   

Abstract

50% of patients with cystic fibrosis (CF) are homozygous for the delta F508 mutation, but the remainder have at least one of many other less common mutations. The 3849 + 10 kb C-->T splice mutation seems to be associated with less severe disease. We report ten CF patients who are hemizygous for this mutation. Three male patients do not have azoospermia (sperm counts 12, 53, and 198 x 10(6)/mL). Another boy died before CF was diagnosed; his genital tract appeared normal at necropsy. All patients had clinically sufficient exocrine pancreatic function. Pulmonary disease was delayed in onset in most of these patients (range < 1 to 16; median 9 years), but then became severe in some, progressing to death (in two) and need for transplantation in one. Sweat chloride concentration was abnormal (80 mmol/L) in one patient but in others was in the intermediate range (45-65 mmol/L). There was substantial variation in pulmonary disease severity within sibships. These observations suggest some dissociation in genetically determined severity between different organs. There was some evidence among these patients of a tendency for disease of the genital tract to become progressively more severe. Perhaps sperm banking should be offered to male patients. We speculate that some normal CF transmembrane conductance regulator is made in patients with this splice abnormality.

Entities:  

Mesh:

Year:  1995        PMID: 7630247     DOI: 10.1016/s0140-6736(95)92165-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

2.  Genotype-phenotype correlation for pulmonary function in cystic fibrosis.

Authors:  J de Gracia; F Mata; A Alvarez; T Casals; S Gatner; M Vendrell; D de la Rosa; L Guarner; E Hermosilla
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

3.  A survey of sexual and reproductive health in men with cystic fibrosis: new challenges for adolescent and adult services.

Authors:  S M Sawyer; B Farrant; B Cerritelli; J Wilson
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

4.  Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.

Authors:  Edward F McKone; Jing Shao; Daisy D Frangolias; Cassie L Keener; Cynthia A Shephard; Federico M Farin; Mark R Tonelli; Peter D Pare; Andrew J Sandford; Moira L Aitken; Terrance J Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

5.  [Atypical cystic fibrosis. First diagnosed by chronic rhinosinusitis].

Authors:  J G Mainz; S Dornaus; C Dopfer; J F Beck; A Müller
Journal:  HNO       Date:  2009-08       Impact factor: 1.284

6.  A Case of Cystic Fibrosis With a Rare Mutation (3849 + 10 kbC > T) and Normal Sweat Chloride Levels.

Authors:  Taha Resid Ozdemir; Ali Kanik
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

Review 7.  Splicing mutations in the CFTR gene as therapeutic targets.

Authors:  Karine Deletang; Magali Taulan-Cadars
Journal:  Gene Ther       Date:  2022-06-02       Impact factor: 4.184

8.  Chronic cough with normal sweat chloride: Phenotypic descriptions of two rare cystic fibrosis genotypes.

Authors:  Hemang Yadav; Kaiser G Lim
Journal:  Respir Med Case Rep       Date:  2015-12-18

9.  Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.

Authors:  David J Sanz; Jennifer A Hollywood; Martina F Scallan; Patrick T Harrison
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

Review 10.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.